StockDrifts LogoStockDrifts

RTW Investments 13F Portfolio ยท Roderick Wong

Portfolio Manager
Roderick Wong
Performance
+11.24% (2026 Q2)
AUM (13F)
$11.71B
# of Holdings
84
Performance Rank
Allocation (Top 20)
69.12%
Latest filing
Q2 2026

Rtw Investments LP Holdings Map

Top 50 Rtw Investments LP Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
MDGL
MADRIGAL PHARMACEUTICALS INC
9.14%1.99M$1.07B
+0.00%(+0)
2025-Q2: 1.99M shares2025-Q3: 1.99M shares2025-Q4: 1.99M shares2026-Q1: 1.99M shares2026-Q2: 1.99M shares
$258.01(+96.65%)
2026-06-30
ARGX
ARGENX SE
5.62%709.4K$658.2M
+0.00%(+0)
2025-Q2: 673.5K shares2025-Q3: 673.5K shares2025-Q4: 673.5K shares2026-Q1: 709.4K shares2026-Q2: 709.4K shares
$373.38(+129.51%)
2026-06-30
PTCT
PTC THERAPEUTICS INC
5.39%7.75M$631.9M
+0.00%(+0)
2025-Q2: 7.75M shares2025-Q3: 7.75M shares2025-Q4: 7.75M shares2026-Q1: 7.75M shares2026-Q2: 7.75M shares
$37.81(+90.36%)
2026-06-30
PTGX
PROTAGONIST THERAPEUTICS INC
5.3%5.06M$620.4M
+0.04%(+2.12K)
2025-Q2: 5.76M shares2025-Q3: 5.76M shares2025-Q4: 5.06M shares2026-Q1: 5.06M shares2026-Q2: 5.06M shares
$23.63(+544.86%)
2026-06-30
CGON
CG ONCOLOGY INC
5.16%8.51M$605.0M
+21.90%(+1.53M)
2025-Q2: 1.70M shares2025-Q3: 1.70M shares2025-Q4: 2.01M shares2026-Q1: 6.98M shares2026-Q2: 8.51M shares
$53.16(+42.74%)
2026-06-30
INSM
INSMED INC
4.41%4.84M$516.3M
+0.00%(+0)
2025-Q2: 3.08M shares2025-Q3: 3.08M shares2025-Q4: 4.84M shares2026-Q1: 4.84M shares2026-Q2: 4.84M shares
$79.98(+57.95%)
2026-06-30
TNGX
TANGO THERAPEUTICS INC
3.71%13.90M$434.5M
+4.51%(+600.00K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 1.49M shares2026-Q1: 13.30M shares2026-Q2: 13.90M shares
$14.66(+74.91%)
2026-06-30
SYRE
SPYRE THERAPEUTICS INC
3.22%4.25M$377.5M
+1.92%(+80.00K)
2025-Q2: 3.62M shares2025-Q3: 3.62M shares2025-Q4: 4.17M shares2026-Q1: 4.17M shares2026-Q2: 4.25M shares
$22.99(+342.93%)
2026-06-30
CELC
CELCUITY INC
2.95%3.30M$345.8M
+8.73%(+265.28K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 550.2K shares2026-Q1: 3.04M shares2026-Q2: 3.30M shares
$101.51(-14.69%)
2026-06-30
ERAS
ERASCA INC
2.81%17.95M$328.8M
+11.08%(+1.79M)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 146.7K shares2026-Q1: 16.16M shares2026-Q2: 17.95M shares
$10.56(+69.15%)
2026-06-30

About Rtw Investments LPโ€™s portfolio

Rtw Investments LP reports $11.71B in US-listed equity holdings across 84 positions in its most recent 13F filing. Its largest disclosed positions are MDGL (9.1%), ARGX (5.6%) and PTCT (5.4%). The top 20 holdings account for 69.12% of reported assets. Its disclosed equity book has returned +42.15% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
MDGL โ€” 9.7% ($1.07B)ARGX โ€” 5.9% ($658.20M)PTCT โ€” 5.7% ($631.88M)PTGX โ€” 5.6% ($620.40M)CGON โ€” 5.5% ($604.96M)INSM โ€” 4.7% ($516.35M)TNGX โ€” 3.9% ($434.53M)SYRE โ€” 3.4% ($377.49M)CELC โ€” 3.1% ($345.76M)ERAS โ€” 3.0% ($328.78M)Other โ€” 49.6% ($5.49B)
50%in top 10
  • MDGL9.7%
  • ARGX5.9%
  • PTCT5.7%
  • PTGX5.6%
  • CGON5.5%
  • INSM4.7%
  • TNGX3.9%
  • SYRE3.4%
  • CELC3.1%
  • ERAS3.0%
  • Other49.6%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
4
GPCRSTRUCTURE THERAPEUTICS INC0.7%
AXGNAXOGEN INC0.4%
DHRDANAHER CORP DEL0.4%
SLDBSOLID BIOSCIENCES INC0.3%
Added to
21
RAREULTRAGENYX PHARMACEUTICAL IN+113.7%
CGONCG ONCOLOGY INC+21.9%
ORKAORUKA THERAPEUTICS INC+52.5%
QUREUNIQURE NV+52.4%
+17 more
Trimmed
4
COGTCOGENT BIOSCIENCES INC-57.7%
HNGEHINGE HEALTH INC-74.1%
NTRANATERA INC-20.0%
TSHATAYSHA GENE THERAPIES INC-0.9%

Unlock alerts, watchlists & AI chat

Sign up free to track Rtw Investments LP, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Rtw Investments LPโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1493215). View Rtw Investments LPโ€™s 13F filings on SEC

More 13F analyses

View all